Xenna Corp.
Executive Summary
Xenna is developing NADPH inhibiting antimetabolite and anti-androgen therapeutics with anticancer potential, but is initially offering a line of consumer products consisting of denaturing dermatologicals for hyperkeratotic nail, skin, and hair conditions.